Showing 1 - 7 results of 7 for search 'Huizhao Su', query time: 0.03s
Refine Results
-
1
-
2
Application of da Vinci robot and laparoscopy on repeat hepatocellular carcinoma by Shuiping Yu, Guandou Yuan, Shiliu Lu, Jiangfa Li, Bo Tang, Fudi Zhong, Huizhao Su, Songqin He
Published 2022-01-01
Article -
3
Retraction Note: LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2 by Guizhi Jia, Yan Wang, Chengjie Lin, Shihui Lai, Hongliang Dai, Zhiqian Wang, Luo Dai, Huizhao Su, Yanjie Song, Naiwen Zhang, Yukuan Feng, Bo Tang
Published 2023-03-01
Article -
4
RETRACTED ARTICLE: LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2 by Guizhi Jia, Yan Wang, Chengjie Lin, Shihui Lai, Hongliang Dai, Zhiqian Wang, Luo Dai, Huizhao Su, Yanjie Song, Naiwen Zhang, Yukuan Feng, Bo Tang
Published 2021-09-01
Article -
5
mTORC1-c-Myc pathway rewires methionine metabolism for HCC progression through suppressing SIRT4 mediated ADP ribosylation of MAT2A by Liang Zhao, Huizhao Su, Xiaomeng Liu, Hongquan Wang, Yukuan Feng, Yan Wang, Haiqiang Chen, Luo Dai, Shihui Lai, Siqi Xu, Chong Li, Jihui Hao, Bo Tang
Published 2022-11-01
Article -
6
LINC00680 enhances hepatocellular carcinoma stemness behavior and chemoresistance by sponging miR-568 to upregulate AKT3 by Gege Shu, Huizhao Su, Zhiqian Wang, Shihui Lai, Yan Wang, Xiaomeng Liu, Luo Dai, Yin Bi, Wei Chen, Weiyu Huang, Ziyan Zhou, Songqing He, Hongliang Dai, Bo Tang
Published 2021-01-01
Article -
7
FBXL19 promotes malignant behaviours by activating MAPK signalling and negatively correlates with prognosis in hepatocellular carcinoma by Min Xun, Jiming Wang, Qiuli Xie, Bo Peng, Zeyuan Li, Zhengya Guo, Yonglian Zeng, Huizhao Su, Mei Yao, Lijuan Liao, Yan Li, Guandou Yuan, Shilian Chen, Songqing He
Published 2023-11-01
Article